HIGHLIGHTS
- who: Pengcheng Yu and colleagues from the First Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, China have published the Article: SFRP4 Is a Potential Biomarker for the Prognosis and Immunotherapy for Gastric Cancer, in the Journal: Journal of Oncology
- what: The aim of this research was to explore the expression of SFRP4 in gastric cancer, its clinical significance, and its relationship with the tumor immune microenvironment.
- how: The data were analyzed using SPSS 26.0 statistical software and graphing was performed using GraphPad Prism 9 software. To examine prognostic values the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.